Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event

AstraZeneca

Status: Completed

Conditions: Cardiovascular Events

Study type: Observational

Funder types: Industry

Identifiers

NCT01395550

NIS-CZA-XXX-2011/1

Details and patient eligibility

About

AstraZeneca was interested in knowing how Cardiologists and Physicians treat patients who have suffered a cardiovascular event.

Enrollment: 88 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients who has experienced cardiovascular events

Exclusion criteria

• Patients with no cardiovascular events.